Cumberland Pharmaceuticals Inc. stock is up 1.8% since 30 days ago. The next earnings date is Mar 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 14 December’s closed higher than November.
Cumberland Pharmaceuticals Inc. focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning, Caldolor, Kristalose, Omeclamox-Pak, Vaprisol and Vibativ.